Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway
Background and aims Diabetic kidney disease (DKD) is one of the most common complications of diabetes. It is reported that mesenchymal stem cells (MSCs) derived exosomes (MSCs-Exo) may have great clinical application potential for the treatment of DKD, but the underlying mechanism has not been illus...
Saved in:
| Main Authors: | Yinghui Wang, Donglin Lu, Shasha Lv, Xiangchun Liu, Gang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2381597 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cells and exosomes: A novel therapeutic approach for aging
by: Dongfeng Lan, et al.
Published: (2025-07-01) -
Progress in the study of the role of mesenchymal stem cell exosomes in heart transplant rejection
by: LIU Dezhao, et al.
Published: (2024-11-01) -
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
by: Ju-El Kim, et al.
Published: (2025-01-01) -
Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure
by: Zhuoran Wang, et al.
Published: (2025-02-01) -
Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes
by: Changlong Hu, et al.
Published: (2024-12-01)